Facebook requires drugmakers to allow user comments

08/14/2011 | Washington Post, The

Beginning today, pharmaceutical firms must allow user comments on most of their Facebook pages to "encourage an authentic dialogue" on the social network. Drugmakers are worried that users will post inappropriate statements, which could prompt regulatory concerns. AstraZeneca deleted a page devoted to depression last week, while Johnson & Johnson intends to remove four pages this week.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC